Company attributes
Industry
Location
Date Incorporated
2008
CIK Number
Investors
Founded Date
2008
Total Funding Amount (USD)
3,000,000
Latest Funding Round Date
September 2020
Other attributes
Company Operating Status
Active
Man's Best Friends Therapeutics (MBFT) is a clinical stage animal health company that is developing gene-based check point inhibitor and immune-modulators for cancer and infectious diseases for the companion animal market using both viral and non-viral proprietary delivery systems. Their lead product is MBFT-201 for canine melanoma.
The company also has 3 infectious disease products in development..
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.